Fulvestrant
Links shared publicly online about this topic
Dr. Goldstein on Fulvestrant in Metastatic Breast Cancer
onclive.com — “Dr. Lori Goldstein from Fox Chase Cancer Center on Fulvestrant in Metastatic Breast Cancer” View full resource at onclive.com
Most Recently Shared on October 26, 2011 at 10:30 pm By:
Dr. Lori Goldstein from @FoxChaseCancer on Fulvestrant in Metastatic Breast Cancer http://t.co/7dmY7xHz #OncLiveTV
Fulvestrant-Chemo Combo Targeted for ER Positive Breast Cancer
newswise.com — “Researchers from New Jersey's only NCI-designated Comprehensive Cancer Center are presenting findings on a combined treatment targeting breast cancer that is stimulated by the hormone estrogen. At focus is how the FDA-approved therapy fulvestrant can influence the effects of chemotherapy drugs on breast cancer cells.” View full resource at newswise.com
Most Recently Shared on April 20, 2009 at 7:27 pm By:
Fulvestrant-Chemo Combo Targeted for ER Positive Breast Cancer http://bit.ly/15xDav
FDA Approves New Dosing for Faslodex (fulvestrant) Injection in Treatment of Metastatic Breast Cancer in HR+ Postmenopausal Women
drugs.com — “Faslodex (fulvestrant) is used to treat metastatic breast cancer. Includes Faslodex side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on September 14, 2010 at 12:58 am By:
FDA Approves New Dosing for Faslodex in Treatment of Metastatic Breast Cancer - http://bit.ly/8ZB720
Breast cancer drug fulvestrant appears more effective in the presence of CK8 and CK18
physorg.com — “Women's responsiveness to the second-line breast cancer drug fulvestrant may depend on whether the cancer cells are expressing two key proteins, Indiana University Bloomington scientists report in this month's Cancer Biology & Therapy.” View full resource at physorg.com
Most Recently Shared on March 10, 2010 at 3:50 pm By:
PhysOrg Health News Health News
Breast cancer drug fulvestrant appears more effective in the presence of CK8 and CK18 http://tw.physorg.com/187440560
FDA Approves High-Dose Fulvestrant for Refractory Metastatic Breast Cancer - QualityPoint Technologies
qualitypointtech.net — “The FDA has approved a 500-mg dose of fulvestrant intramuscular injection for the treatment of HR+ metastatic breast cancer in postmenopausal women with disease progression after antiestrogen therapy.n Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on September 17, 2010 at 5:12 pm By:
FDA Approves High-Dose Fulvestrant for Refractory Metastatic Breast Cancer: The FDA has approved a 500-mg dose of ... http://bit.ly/bBstva
Medical News: SABCS: Higher Dose of Fulvestrant Slows Breast Cancer - in Meeting Coverage, SABCS from MedPage Today
medpagetoday.com — “SAN ANTONIO -- Women with metastatic breast cancer had a modest but statistically significant improvement in time to progression when treated with 500 mg of fulvestrant (Faslodex) -- double the usual” View full resource at medpagetoday.com
Most Recently Shared on December 14, 2009 at 8:07 pm By:
SABCS: Higher Dose of Fulvestrant Slows Breast Cancer (CME/CE) SAN ANTONIO (MedPage Today) -- Women with metastatic b.. http://bit.ly/6aImhF
Oncology Medical Article | An Open-Label Randomized Phase III Study of Fulvestrant and Anastrozole in Combination Compared With Anastrozole Alone as First-Line Therapy for Patients With Receptor-Positive Postmenopausal Breast Cancer
mdlinx.com — “Oncology Medical Article: An Open-Label Randomized Phase III Study of Fulvestrant and Anastrozole in Combination Compared With Anastrozole Alone as First-Line Therapy for Patients With Receptor-Positive Postmenopausal Breast Cancer” View full resource at mdlinx.com
Most Recently Shared on March 15, 2012 at 6:26 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
An Open-Label Randomized Phase III Study of Fulvestrant and Anastrozole in Combination Compared With A... http://t.co/DUI4fAsG #oncology
Oncology News - A randomized trial of combination anastrozole plus gefitinib and of combination fulvestrant plus gefitinib in the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer |3985513
mdlinx.com — “Oncology Medical Article: A randomized trial of combination anastrozole plus gefitinib and of combination fulvestrant plus gefitinib in the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer” View full resource at mdlinx.com
Most Recently Shared on March 23, 2012 at 5:09 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
A randomized trial of combination anastrozole plus gefitinib and of combination fulvestrant plus gefit... http://t.co/jdwD5w6i #oncology
Breast Cancer Drugs May Fight Cervical Cancer, Too
health.msn.com — “Breast Cancer Drugs May Fight Cervical Cancer, Too” View full resource at health.msn.com
Most Recently Shared on November 9, 2009 at 10:49 pm By:
Breast Cancer Drugs May Fight Cervical Cancer, Too http://bit.ly/4B36Ui
Lombardi Researchers Find Investigational Agent Reduces Tumor Resistance To Breast Cancer Therapy
medicalnewstoday.com — “Researchers at georgetown lombardi comprehensive cancer center have found a way to cleverly override signals that tell breast cancer cells to keep surviving in the face of anticancer treatment. t” View full resource at medicalnewstoday.com
Most Recently Shared on January 7, 2010 at 11:12 am By:
Lombardi Researchers Find Investigational Agent Reduces Tumor Resistance To Breast Cancer Therapy http://mnt.to/3vZm
Oncology Medical News about Breast cancer
mdlinx.com — “Prolonged time to progression with fulvestrant for metastatic breast cancer” View full resource at mdlinx.com
Most Recently Shared on April 13, 2010 at 11:24 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Prolonged time to progression with fulvestrant for metastatic breast cancer: Medical Oncology http://bit.ly/bYPKBG #oncology
Breast Cancer Drugs May Fight Cervical Cancer, Too - myOptumHealth
myoptumhealth.com — “Read the news article Breast Cancer Drugs May Fight Cervical Cancer, Too at www.myOptumHealth.com” View full resource at myoptumhealth.com
Most Recently Shared on November 10, 2009 at 2:17 am By:
Breast Cancer Drugs May Fight Cervical Cancer, Too: Study in mice reports success with drugs that inhibit estrogen http://bit.ly/4vKGUb
New Drugs, New Combinations Fight Breast Cancer - Drugs.com MedNews
drugs.com — “New therapies and new spins on existing treatments are offering hope for patients with breast cancer, especially those with metastatic disease, according to res” View full resource at drugs.com
Most Recently Shared on December 13, 2009 at 9:35 pm By:
New Drugs, New Combinations Fight Breast Cancer - http://bit.ly/7q3ZVD
Breast Cancer Drugs May Fight Cervical Cancer, Too - Drugs.com MedNews
drugs.com — “Two drugs used to treat breast cancer and osteoporosis eliminated cervical cancer in mice, according to a new study. The drugs also cleared precancerous growths” View full resource at drugs.com
Most Recently Shared on November 10, 2009 at 6:45 am By:
Breast Cancer Drugs May Fight Cervical Cancer, Too - http://bit.ly/3MPJ0V
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Editor
Editors of Oncology & Biotech News/Oncology Net Guide/OncNurse/Contemporary Oncology, on cancer news from pharma, trials, technology, & more.
-
Thom Canalichio
Bringing you the Latest Newswise Medical content.
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
Advertisement
